A Study of Rucaparib Administered With Radiation in Patients With Triple Negative Breast Cancer With an Incomplete Response Following Chemotherapy
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Rucaparib|RADIATION: Radiotherapy
Sponsor: Memorial Sloan Kettering Cancer Center
Collaborators: Clovis Oncology, Inc.